Nasdaq Down 1.5%; Immunovant Shares Spike Higher
Portfolio Pulse from Lisa Levin
US stocks traded lower with the Dow Jones falling more than 400 points and NASDAQ falling 1.48%. United Natural Foods Inc reported mixed results for its fourth quarter, missing sales growth consensus but beating EPS consensus. The company's shares fell by 25%. Soleno Therapeutics, Femasys Inc, and Immunovant saw significant increases in their share prices due to positive news. TransCode Therapeutics and New Pacific Metals Corp saw their shares drop.
September 26, 2023 | 6:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Femasys Inc shares shot up 260% after the company received FDA 510(k) clearance for FemaSeed.
The company's FDA clearance for FemaSeed led to a significant increase in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Immunovant shares gained 100% after Alfasigma agreed to acquire Intercept Pharmaceuticals.
The news of Alfasigma's acquisition of Intercept Pharmaceuticals led to a significant increase in Immunovant's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Soleno Therapeutics shares shot up 442% after the company released positive top-line results from a study.
The company's positive top-line results from a study led to a significant increase in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
New Pacific Metals Corp shares fell 13% after the company announced a bought deal financing.
The company's announcement of a bought deal financing led to a drop in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics shares dropped 71% after the company priced its public offering of shares.
The company's pricing of its public offering led to a significant drop in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
United Natural Foods reported mixed Q4 results, missing sales growth consensus but beating EPS consensus. Shares fell by 25%.
The company's mixed results and guidance led to a significant drop in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100